- Home
- UONE vs STRO Comparison
UONE vs STRO Comparison
Compare UONE & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONE
- STRO
- Stock Information
- Founded
- UONE 1980
- STRO 2003
- Country
- UONE United States
- STRO United States
- Employees
- UONE N/A
- STRO N/A
- Industry
- UONE Broadcasting
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UONE Consumer Discretionary
- STRO Health Care
- Exchange
- UONE Nasdaq
- STRO Nasdaq
- Market Cap
- UONE 72.2M
- STRO 77.7M
- IPO Year
- UONE N/A
- STRO 2018
- Fundamental
- Price
- UONE $1.59
- STRO $0.81
- Analyst Decision
- UONE
- STRO Hold
- Analyst Count
- UONE 0
- STRO 7
- Target Price
- UONE N/A
- STRO $3.97
- AVG Volume (30 Days)
- UONE 35.8K
- STRO 455.0K
- Earning Date
- UONE 08-19-2025
- STRO 08-12-2025
- Dividend Yield
- UONE N/A
- STRO N/A
- EPS Growth
- UONE N/A
- STRO N/A
- EPS
- UONE N/A
- STRO N/A
- Revenue
- UONE $437,499,000.00
- STRO $66,434,000.00
- Revenue This Year
- UONE N/A
- STRO N/A
- Revenue Next Year
- UONE N/A
- STRO N/A
- P/E Ratio
- UONE N/A
- STRO N/A
- Revenue Growth
- UONE N/A
- STRO N/A
- 52 Week Low
- UONE $1.23
- STRO $0.52
- 52 Week High
- UONE $2.27
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- UONE 40.84
- STRO 49.06
- Support Level
- UONE $1.70
- STRO $0.74
- Resistance Level
- UONE $1.86
- STRO $0.91
- Average True Range (ATR)
- UONE 0.07
- STRO 0.08
- MACD
- UONE -0.03
- STRO -0.00
- Stochastic Oscillator
- UONE 14.71
- STRO 21.20
About UONE Urban One Inc.
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.